Additional information
White Powder
158401-51-5
ACI-037712
122.5-122.7°C
C7H18ClN2O4P.2HCl
333.6
Ambient
2-8°C
Anticancer
Pharmaceutical Impurity Standards
(3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride)
(3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride)
3-[[2-[(2-Chloroethyl)amino]ethyl]amino]propyl Monophosphate Dihydrochloride





![LINAGLIPTIN DIMER (25 mg) (N¹,N²-Bis{(R)-1-[7-(but-2-yn-1-yl)-3-methyl-1-{(4-methylquinazolin-2-yl)methyl}-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}phthalamide)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)